Ming-min Cai

Development and validation of a sensitive LC–MS/MS method without derivatization/ion‐pairing agents for etimicin quantification in rat plasma, internal ear and kidney

Qianying Chen, Guangji Wang, Jingwei Zhang, 2017, Journal of pharmaceutical and biomedical analysis.

Mechanisms and pharmacokinetic/pharmacodynamic profiles underlying the low nephrotoxicity and ototoxicity of etimicin

Guang-Ji Wang, Yi-Wen Zheng, Jingwei Zhang, 2020, Acta Pharmacologica Sinica.

Mechanisms and pharmacokinetic/pharmacodynamic profiles underlying the low nephrotoxicity and ototoxicity of etimicin

Guang-Ji Wang, Yi-Wen Zheng, Jingwei Zhang, 2020, Acta Pharmacologica Sinica.

Phase I study to evaluate of the gastric pH-dependent drug interaction between famitinib and the proton pump inhibitor omeprazole in healthy subjects

Ting Dou, Ming-min Cai, Wei Qian, 2022, Investigational New Drugs.

Apatinib, a selective VEGFR2 inhibitor, improves the delivery of chemotherapeutic agents to tumors by normalizing tumor vessels in LoVo colon cancer xenograft mice

Guang-Ji Wang, Jingwei Zhang, F. Zhou, 2018, Acta Pharmacologica Sinica.

Effect of a moderate CYP3A inducer efavirenz on the pharmacokinetics of fuzuloparib: An open-label, fixed sequence study in Chinese healthy male subjects

Ting Dou, Ming-min Cai, Wei Qian, 2023, Investigational New Drugs.

Effects of rifampicin on antineoplastic drug pyrotinib maleate pharmacokinetics in healthy subjects

Ting Dou, Ming-min Cai, Wei Qian, 2022, Investigational new drugs.

Apatinib, a selective VEGFR2 inhibitor, improves the delivery of chemotherapeutic agents to tumors by normalizing tumor vessels in LoVo colon cancer xenograft mice

Guang-Ji Wang, Jingwei Zhang, F. Zhou, 2018, Acta Pharmacologica Sinica.